The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Early Mortality in Adults Initiating Antiretroviral Therapy (ART) in Low- and Middle-Income Countries (LMIC): A Systematic Review and Meta-Analysis
Open accessAbstract
BACKGROUND: We systematically reviewed observational studies of early mortality post-antiretroviral therapy (ART) initiation in low- and middle-income countries (LMIC) in Asia, Africa, and Central and South America, as defined by the World Bank, to summarize what is known. METHODS AND FINDINGS: Studies published in English between January 1996 and December 2010 were searched in Medline and EMBASE. Three independent reviewers examined studies of mortality within one year post-ART. An article was included if the study was conducted in a LMIC, participants were initiating ART in a non-clinical trial setting and were ≥15 years. Fifty studies were included; 38 (76%) from sub-Saharan Africa (SSA), 5 (10%) from Asia, 2 (4%) from the Americas, and 5 (10%) were multi-regional. Median follow-up time and pre-ART CD4 cell count ranged from 3-55 months and 11-192 cells/mm(3), respectively. Loss-to-follow-up, reported in 40 (80%) studies, ranged from 0.3%-27%. Overall, SSA had the highest pooled 12-month mortality probability of 0.17 (95% CI 0.11-0.24) versus 0.11 (95% CI 0.10-0.13) for Asia, and 0.07 (95% CI 0.007-0.20) for the Americas. Of 14 (28%) studies reporting cause-specific mortality, tuberculosis (TB) (5%-44%), wasting (5%-53%), advanced HIV (20%-37%), and chronic diarrhea (10%-25%) were most common. Independent factors associated with early mortality in 30 (60%) studies included: low baseline CD4 cell count, male sex, advanced World Health Organization clinical stage, low body mass index, anemia, age greater than 40 years, and pre-ART quantitative HIV RNA. CONCLUSIONS: Significant heterogeneity in outcomes and in methods of reporting outcomes exist among published studies evaluating mortality in the first year after ART initiation in LMIC. Early mortality rates are highest in SSA, and opportunistic illnesses such as TB and wasting syndrome are the most common reported causes of death. Strategies addressing modifiable risk factors associated with early death are urgently needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 2×
“If there was an evidence of variation between the studies, a random effects model was used to estimate the combined mortality rate and corresponding 95% confidence interval using standard methods [10], otherwise a fixed-effects model was used.”
MethodQuantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,405
Sterne, J. A. C., Sutton, A. J., Ioannidis, J. P. A., Terrin, N., Jones, D. R., Lau, J., Carpenter, J., Rucker, G., Harbord, R. M., Schmid, C. H., et al. (2011) · BMJ · doi:10.1136/bmj.d4002 · Cited by 7,709 · cited 1×
“Although the presence of publication bias is a common explanation to an asymmetric funnel plot, data presented here are observational data without any intervention so the funnel plot asymmetry could also be due to heterogeneity in the data [25].”
BackgroundParmar, M. K. B., Torri, V., & Stewart, L. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19981230)17:24<2815::aid-sim110>3.0.co;2-8 · Cited by 4,802
Granich, R. M., Gilks, C. F., Dye, C., De Cock, K. M., & Williams, B. G. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61697-9 · Cited by 1,988
HIV Infection, Inflammation, Immunosenescence, and Aging
Deeks, S. G. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-042909-093756 · Cited by 1,349
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
Kitahata, M. M., Gange, S. J., Abraham, A. G., Merriman, B., Saag, M. S., Justice, A. C., Hogg, R. S., Deeks, S. G., Eron, J. J., Brooks, J. T., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0807252 · Cited by 1,105
A general parametric approach to the meta‐analysis of randomized clinical trials
Whitehead, A., & Whitehead, J. (1991) · Statistics in Medicine · doi:10.1002/sim.4780101105 · Cited by 750
Stringer, J. S. A., Zulu, I., Levy, J., Stringer, E. M., Mwango, A., Chi, B. H., Mtonga, V., Reid, S., Cantrell, R. A., Bulterys, M., et al. (2006) · JAMA · doi:10.1001/jama.296.7.782 · Cited by 655
Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa
Lawn, S. D., Harries, A. D., Anglaret, X., Myer, L., & Wood, R. (2008) · AIDS · doi:10.1097/qad.0b013e32830007cd · Cited by 639
Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa
Coetzee, D., Hildebrand, K., Boulle, A., Maartens, G., Louis, F., Labatala, V., Reuter, H., Ntwana, N., & Goemaere, E. (2004) · AIDS · doi:10.1097/00002030-200404090-00006 · Cited by 584
Ferradini, L., Jeannin, A., Pinoges, L., Izopet, J., Odhiambo, D., Mankhambo, L., Karungi, G., Szumilin, E., Balandine, S., Fedida, G., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68580-2 · Cited by 450
Weidle, P. J., Malamba, S., Mwebaze, R., Sozi, C., Rukundo, G., Downing, R., Hanson, D., Ochola, D., Mugyenyi, P., Mermin, J., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09330-3 · Cited by 315
Dabis, F. (2008) · Bulletin of the World Health Organization · doi:10.2471/blt.07.044248 · Cited by 306
Antiretroviral Therapy in a Thousand Patients with AIDS in Haiti
Severe, P., Leger, P., Charles, M., Noel, F., Bonhomme, G., Bois, G., George, E., Kenel-Pierre, S., Wright, P. F., Gulick, R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051908 · Cited by 291
Zachariah, R., Fitzgerald, M., Massaquoi, M., Pasulani, O., Arnould, L., Makombe, S., & Harries, A. D. (2006) · AIDS · doi:10.1097/qad.0b013e32801086b0 · Cited by 284
Etard, J.-F., Ndiaye, I., Thierry-Mieg, M., Guèye, N. F. N., Guèye, P. M., Lanièce, I., Dieng, A. B., Diouf, A., Laurent, C., Mboup, S., et al. (2006) · AIDS · doi:10.1097/01.aids.0000226959.87471.01 · Cited by 278
Johannessen, A., Naman, E., Ngowi, B. J., Sandvik, L., Matee, M. I., Aglen, H. E., Gundersen, S. G., & Bruun, J. N. (2008) · BMC Infectious Diseases · doi:10.1186/1471-2334-8-52 · Cited by 269
Toure, S., Kouadio, B., Seyler, C., Traore, M., Dakoury-Dogbo, N., Duvignac, J., Diakite, N., Karcher, S., Grundmann, C., Marlink, R., et al. (2008) · AIDS · doi:10.1097/qad.0b013e3282f768f8 · Cited by 185
Calmy, A., Pinoges, L., Szumilin, E., Zachariah, R., Ford, N., & Ferradini, L. (2006) · AIDS · doi:10.1097/01.aids.0000226957.79847.d6 · Cited by 163
Bekker, L., Myer, L., Orrell, C., Lawn, S. D., & Wood, R. (2006) · PubMed · doi:10.7196/samj.1072 · Cited by 158
Antiretroviral therapy and early mortality in South Africa
Boulle, A. (2008) · Bulletin of the World Health Organization · doi:10.2471/blt.07.045294 · Cited by 151
Abaasa, A. M., Todd, J., Ekoru, K., Kalyango, J. N., Levin, J. B., Odeke, E., & Karamagi, C. (2008) · BMC Health Services Research · doi:10.1186/1472-6963-8-241 · Cited by 143
Djomand, G., Roels, T. H., Ellerbrock, T. V., Hanson, D. L., Diomandé, F. V. K., Monga, B., Maurice, C., Nkengasong, J. N., Konan-Koko, R., Kadio, A., et al. (2003) · AIDS · doi:10.1097/00002030-200317003-00002 · Cited by 143
Lawn, S. D., Myer, L., Bekker, L., & Wood, R. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-59 · Cited by 134
Mulenga, L., Kruse, G. R., Lakhi, S., Cantrell, R. A., Reid, S. E., Zulu, I., Stringer, E. M., Krishnasami, Z., Mwinga, A., Saag, M. S., et al. (2008) · AIDS · doi:10.1097/qad.0b013e328307a051 · Cited by 133
Rougemont, M., Stoll, B., Elia, N., & Ngang, P. (2009) · AIDS Research and Therapy · doi:10.1186/1742-6405-6-21 · Cited by 120
Marazzi, M. C., Liotta, G., Germano, P., Guidotti, G., Altan, A. M. D., Ceffa, S., Lio, M. M. S., Nielsen‐Saines, K., & Palombi, L. (2008) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2007.0217 · Cited by 115
Palombi, L., Marazzi, M. C., Guidotti, G., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/593312 · Cited by 112
Lawn, S. D., Harries, A. D., & Wood, R. (2009) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e328333850f · Cited by 106
Mortality and loss to follow-up among HAART initiators in rural South Africa
MacPherson, P., Moshabela, M., Martinson, N. A., & Pronyk, P. (2008) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2008.10.001 · Cited by 104
Karcher, H., Omondi, A. A., Odera, J., Kunz, A., & Harms, G. (2007) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2007.01830.x · Cited by 103
Determinants of survival in adult HIV patients on antiretroviral therapy in Oromiyaa, Ethiopia
Alemu, A., & Sebastiån, M. S. (2010) · Global Health Action · doi:10.3402/gha.v3i0.5398 · Cited by 100
Tuboi, S. H., Schechter, M., McGowan, C. C., César, C., Krolewiecki, A. J., Cahn, P. E., Wolff, M. J., Pape, J. W., Padgett, D., Madero, J. S., et al. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181a44f0a · Cited by 88
Sanne, I., Westreich, D. J., MacPhail, A. P., Rubel, D., Majuba, P., & Rie, A. V. (2009) · Journal of the International AIDS Society · doi:10.1186/1758-2652-12-38 · Cited by 84
Supervision, monitoring and evaluation of nationwide scale-up of antiretroviral therapy in Malawi
Harries, A. D. (2006) · Bulletin of the World Health Organization · doi:10.2471/blt.05.023952 · Cited by 80
Alibhai (2010) · International Journal of Women s Health · doi:10.2147/ijwh.s9408 · Cited by 73
Lowrance, D. W., Makombe, S. D., Harries, A. D., Yu, J. K., Aberle-Grasse, J. M., Eiger, O., Shiraishi, R. W., Marston, B. J., Ellerbrock, T. V., & Libamba, E. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181378ed2 · Cited by 66
Blanco, J. R., Caro-Murillo, A. M., Cachafeiro, S. P., Gutiérrez, F., Iribarren, J. A., González‐García, J., Ferrando‐Martínez, S., Navarro, G., & Moreno, S. (2010) · PubMed · Cited by 55
Field Assessment of Generic Antiretroviral Drugs: A Prospective Cohort Study in Cameroon
Bourgeois, A., Laurent, C., Mougnutou, R., Nkoué, N., Lactuock, B., Ciaffi, L., Liégeois, F., Andrieux‐Meyer, I., Zekeng, L. A., Calmy, A., et al. (2005) · Antiviral Therapy · doi:10.1177/135965350501000208 · Cited by 50
Bisson, G. P., Nthobatsong, R., Thakur, R., Lesetedi, G., Vinekar, K. S., Tebas, P., Bennett, J. E., Gluckman, S. J., Gaolathe, T., & MacGregor, R. R. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318183181e · Cited by 46
Self-citationO'Brien, D. P., Venis, S., Greig, J. E., Shanks, L., Ellman, T., Sabapathy, K., Frigati, L. J., & Mills, C. (2010) · Conflict and Health · doi:10.1186/1752-1505-4-12 · Cited by 43
Laurent, C., Bourgeois, A., Mpoudi‐Ngolé, E., Ciaffi, L., Kouanfack, C., Mougnutou, R., Nkoué, N., Calmy, A., Koulla‐Shiro, S., & Delaporte, É. (2008) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2007.0219 · Cited by 41
Makombe, S. D., Jahn, A., Tweya, H. M., Chuka, S., Yu, J. K., Hochgesang, M., Aberle-Grasse, J. M., Pasulani, O., Schouten, E. J., Kamoto, K., et al. (2007) · Europe PMC (PubMed Central) · doi:10.2471/blt.07.041434 · Cited by 38
Makombe, S. D., Harries, A. D., Yu, J. K., Hochgesang, M., Mhango, E., Weigel, R., Pasulani, O., Fitzgerald, M. G., Schouten, E. J., & Libamba, E. (2008) · Tropical Doctor · doi:10.1258/td.2007.060023 · Cited by 36
Survival and Quality of Life Among HIV-Positive People on Antiretroviral Therapy in Cambodia
Morineau, G., Vun, M. C., Barennes, H., Wolf, R., Song, N., Prybylski, D., & Natpratan, C. (2009) · AIDS Patient Care and STDs · doi:10.1089/apc.2008.0241 · Cited by 30
Banda, A. C., Makombe, S. D., Jahn, A., Tweya, H. M., Chuka, S., Yu, J. K., Hedt‐Gauthier, B., Weigel, R., Nkhata, A., Schouten, E. J., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001445 · Cited by 12
Cited by
Lankowski, A. J., Siedner, M. J., Bangsberg, D. R., & Tsai, A. C. (2014) · AIDS and Behavior · doi:10.1007/s10461-014-0729-8 · Cited by 260
Jarvis, J. N., Leeme, T. B., Molefi, M., Chofle, A. A., Bidwell, G., Tsholo, K., Tlhako, N., Mawoko, N., Patel, R. K. K., Tenforde, M. W., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy515 · Cited by 86
Self-citationAuld, A. F., Agizew, T., Mathoma, A., Boyd, R., Date, A., Pals, S. L., Serumola, C., Mathebula, U., Alexander, H., Ellerbrock, T. V., et al. (2020) · BMC Medicine · doi:10.1186/s12916-019-1489-0 · Cited by 14
Metadata
- Authors
- Gupta, A., Nadkarni, G., Yang, W.-T., Chandrasekhar, A., Gupte, N., Bisson, G. P., Hosseinipour, M., & Gummadi, N.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-12-29
- Volume
- 6
- Issue
- 12
- Pages
- e28691
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2037073363
- Cited by
- 254
- References
- 51
- FWCI
- 1.83
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.